scholarly journals Subjective cognitive impairment differs by racial/ethnic groups and sociodemographic factors: The Multi‐Ethnic Study of Atherosclerosis and Alzheimer’s Disease (MESA‐MIND)

2020 ◽  
Vol 16 (S6) ◽  
Author(s):  
Timothy M. Hughes ◽  
Khadijah Winkey ◽  
Bonnie C. Sachs ◽  
Annette L. Fitzpatrick ◽  
Suzanne Craft ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Ethnic Groups ◽  
Sociodemographic Factors ◽  
Subjective Cognitive Impairment ◽  
Ethnic Study ◽  
Racial Ethnic

Subjective cognitive impairment and Alzheimer's disease: a two year follow up of 51 subjects during two years

2015 ◽  
Vol 13 (4) ◽  
pp. 462-471 ◽  
Author(s):  
Nathalie Sambuchi ◽  
Isabelle Muraccioli ◽  
Béatrice Alescio-Lautier ◽  
Véronique Paban ◽  
Roland Sambuc ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Subjective Cognitive Impairment

scholarly journals Dementia Care in Diverse Older Adults in the U.S. Deep South and the Rest of the United States

2021 ◽  
pp. 1-13
Author(s):  
Maria Pisu ◽  
Roy C. Martin ◽  
Liang Shan ◽  
Giovanna Pilonieta ◽  
Richard E. Kennedy ◽  
...  
Keyword(s):  
United States ◽  
Alzheimer’S Disease ◽  
Older Adults ◽  
Alzheimer's Disease ◽  
Drug Use ◽  
Ethnic Groups ◽  
The United States ◽  
Deep South ◽  
Racial Ethnic ◽  
The U.S

Background: Use of specialists and recommended drugs has beneficial effects for older adults living with Alzheimer’s disease and related dementia (ADRD). Gaps in care may exist for minorities, e.g., Blacks, and especially in the United States (U.S.) Deep South (DS), a poor U.S. region with rising ADRD cases and minority overrepresentation. Currently, we have little understanding of ADRD care utilization in diverse populations in this region and elsewhere in the U.S. (non-DS), and the factors that adversely impact it. Objective: To examine utilization of specialists and ADRD drugs (outcomes) in racial/ethnic groups of older adults with ADRD and the personal or context-level factors affecting these outcomes in DS and non-DS. Methods: We obtained outcomes and personal-level covariates from claims for 127,512 Medicare beneficiaries with ADRD in 2013–2015, and combined county-level data in exploratory factor analysis to define context-level covariates. Adjusted analyses tested significant association of outcomes with Black/White race and other factors in DS and non-DS. Results: Across racial/ethnic groups, 33%–43% in DS and 43%–50% in non-DS used specialists; 47%–55% in DS and 41%–48% in non-DS used ADRD drugs. In adjusted analyses, differences between Blacks and Whites were not significant. Vascular dementia, comorbidities, poverty, and context-level factor “Availability of Medical Resources” were associated with specialist use; Alzheimer’s disease and senile dementia, comorbidities, and specialist use were associated with drug use. In non-DS only, other individual, context-level covariates were associated with the outcomes. Conclusion: We did not observe significant gaps in ADRD care in DS and non-DS; however, research should further examine determinants of low specialist and drug use in these regions.

The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease

2008 ◽  
Vol 4 (1S1) ◽  
pp. S98-S108 ◽  
Author(s):  
Barry Reisberg ◽  
Leslie Prichep ◽  
Lisa Mosconi ◽  
E. Roy John ◽  
Lidia Glodzik-Sobanska ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Subjective Cognitive Impairment

scholarly journals Spatial navigation measured by the Floor Maze Test in patients with subjective cognitive impairment, mild cognitive impairment, and mild Alzheimer's disease

2015 ◽  
Vol 27 (8) ◽  
pp. 1401-1409 ◽  
Author(s):  
Gro Gujord Tangen ◽  
Knut Engedal ◽  
Astrid Bergland ◽  
Tron Anders Moger ◽  
Oskar Hansson ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cognitive Impairment ◽  
Executive Function ◽  
Mild Cognitive Impairment ◽  
Spatial Navigation ◽  
Word List ◽  
Cognitive Test ◽  
Subjective Cognitive Impairment ◽  
Maze Test

ABSTRACTBackground:Impaired spatial navigation is an early sign of Alzheimer's disease (AD), but this can be difficult to assess in clinical practice. We examined how the performance on the Floor Maze Test (FMT), which combines navigation with walking, differed between patients with subjective cognitive impairment (SCI), mild cognitive impairment (MCI), and mild AD. We also explored if there was a significant relationship between the FMT and the cognitive tests or sociodemographic factors.Methods:The study included 128 patients from a memory clinic classified as having SCI (n = 19), MCI (n = 20), and mild AD (n = 89). Spatial navigation was assessed by having the patients walk through the FMT, a two-dimensional maze. Both timed measures and number of errors were recorded. Cognitive function was assessed by the Word List Memory test, the Clock Drawing test, the Trail Making tests (TMT) A and B, and the Mini Mental Status Examination (MMSE).Results:The patients with MCI were slower than those with SCI, while the patients with mild AD more frequently completed the FMT with errors or gave up than the patients with MCI. Performance on the FMT was significantly associated with executive function (measured by TMT-B).Conclusions:The performances on the FMT worsened with increasing severity of cognitive impairment, and the FMT was primarily associated with executive function. The explained variance was relatively low, which may indicate that the standard cognitive test battery does not capture impairments of spatial navigation.

Sign in / Sign up

Export Citation Format

Share Document